Antiarrhythmic Drugs Handbook from C.H.I.P.S.

Novel Therapeutic Targets for Antiarrhythmic Drugs
edited by George Edward Billman

Profiles potential treatment approaches for cardiac arrhythmias!

Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. It offers both practitioners and researchers a one-stop guide that brings together previously dispersed information.


  • comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs
  • addresses safety pharmacology, including the concept of "repolarization reserve," safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs
  • describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets
  • describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids)


  1. Introduction
  2. Myocardial potassium channels: primary determinants of action potential repolarization
  3. The "funny" pacemaker current
  4. Arrhythmia mechanisms in ischemia and infarction
  5. Antiarrhythmic drug classification
  6. Repolarization reserve and proarrhythmic risk
  7. Safety Challenges in the development of novel antiarrhythmic drugs
  8. Safety Pharmacology and regulatory issues in the development of antiarrhythmic medications.
  9. Ion channel remodeling and arrhythmias
  10. Redox modification of ryanodine receptors by heart failure and cardiac arrhythmias: a potential therapeutic target
  11. Targeting sodium/calcium exchange as an antiarrhythmic strategy
  12. Calcium/calmodulin-dependent protein kinase II (CaMKII) - Modulation of ion currents and potential role for arrhythmias
  13. Selective targeting of ventricular potassium channels for arrhythmia suppression: feasible or risible?
  14. Cardiac sarcolemmal ATP-sensitive potassium channel antagonists: a class of drugs that may selectively target the ischemic myocardium
  15. Mitochondrial Origin of Ischemia-Reperfusion Arrhythmias: cardiac mitochondria as a novel target for antiarrhythmic drugs
  16. Cardiac gap junction modulators: a new target for antiarrhythmic drugs
  17. Novel Pharmacological Targets for the Management of Atrial Fibrillation
  18. Ultra-rapid delayed rectifier potassium current, IKur: a therapeutic target for atrial arrhythmias
  19. Effects of endurance exercise training on cardiac autonomic regulation and susceptibility to sudden cardiac death: a non-pharmacological approach for the prevention of ventricular fibrillation
  20. Dietary Omega-3 fatty acids as a Non-pharmacological Antiarrhythmic Intervention


click here to see books • videos • cd-roms of related interest


Novel Therapeutic Targets for Antiarrhythmic Drugs
edited by George Edward Billman
2010 • 578 pages • $156.95 + shipping
Texas residents please add 6.75 % sales tax

Go to Top of Page

copyright © 1997-2012 Culinary and Hospitality Industry Publications Services